Alamar Biosciences, Inc. (ALMR) FY2026 Q2 P&L / Income Statement

Alamar Biosciences, Inc. (ALMR) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service (2 categories). Revenue and costs use their disclosed categories.

Total revenue

29,427,000 US dollars

Total cost of revenue

11,709,000 US dollars

Gross profit

17,718,000 US dollars

Total operating expenses

31,250,000 US dollars

Loss from operations

negative 13,532,000 US dollars

Other income (expense), net (calculated)

240,000 US dollars

Net loss before income tax

negative 13,292,000 US dollars

Provision (benefit) for income taxes

negative 93,000 US dollars

Net loss

negative 13,199,000 US dollars

Product Revenue revenue

23,269,000 US dollars

Service and Other Revenue revenue

6,158,000 US dollars

Product Revenue cost of revenue

9,858,000 US dollars

Service and Other Revenue cost of revenue

1,851,000 US dollars

Research and development

13,817,000 US dollars

Selling, general and administrative

17,433,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.